摘要 |
The present invention relates to macrocyclic compounds of Formula I: or pharmaceutically acceptable salts thereof or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are JAK/ ALK inhibitors useful in the treatment of JAK/ALK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer. |
申请人 |
INCYTE CORPORATION;COMBS, ANDREW, PAUL;SPARKS, RICHARD, B.;YUE, EDDY, W.;FENG, HAO;BOWER, MICHAEL, JASON;ZHU, WENYU |
发明人 |
COMBS, ANDREW, PAUL;SPARKS, RICHARD, B.;YUE, EDDY, W.;FENG, HAO;BOWER, MICHAEL, JASON;ZHU, WENYU |